Synergetic regulation of cancer cells and exhausted T cells to fight cold tumors with a fluorinated EGCG-based nanocomplex

Morris EC, Neelapu SS, Giavridis T, Sadelain M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat Rev Immunol. 2022;22(2):85–96.

Chowell D, Yoo SK, Valero C, Pastore A, Krishna C, Lee M, Hoen D, Shi H, Kelly DW, Patel N, Makarov V, Ma X, Vuong L, Sabio EY, Weiss K, Kuo F, Lenz TL, Samstein RM, Riaz N, Adusumilli PS, Balachandran VP, Plitas G, Ari Hakimi A, Abdel-Wahab O, Shoushtari AN, Postow MA, Motzer RJ, Ladanyi M, Zehir A, Berger MF, Gonen M, Morris LGT, Weinhold N, Chan T. A., Improved prediction of immune checkpoint blockade efficacy across multiple cancer types. Nat Biotechnol. 2022;40(4):499–506.

Kubli SP, Berger T, Araujo DV, Siu LL, Mak TW. Beyond immune checkpoint blockade: emerging immunological strategies. Nat Rev Drug Discov. 2021;20(12):899–919.

Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350–5.

Han HS, Jeong S, Kim H, Kim HD, Kim AR, Kwon M, Park SH, Woo CG, Kim HK, Lee KH, Seo SP, Kang HW, Kim WT, Kim WJ, Yun SJ, Shin EC. TOX-expressing terminally exhausted tumor-infiltrating CD8(+) T cells are reinvigorated by co-blockade of PD-1 and TIGIT in Bladder cancer. Cancer Lett. 2021;499:137–47.

McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T cell exhaustion during chronic viral Infection and Cancer. Annu Rev Immunol. 2019;37:457–95.

Arcia-Anaya D, Elliott T. STAT5A antagonizes TOX in CD8(+) T cell exhaustion. Nat Rev Immunol. 2023;23(2):73.

Chen C, Ni X, Jia S, Liang Y, Wu X, Kong D, Ding D. Massively evoking immunogenic cell death by focused mitochondrial oxidative stress using an AIE Luminogen with a twisted molecular structure. Adv Mater 2019, 31 (52), e1904914.

Finlay D, Cantrell DA. Metabolism, migration and memory in cytotoxic T cells. Nat Rev Immunol. 2011;11(2):109–17.

Chen SW, Zhu SQ, Pei X, Qiu BQ, Xiong D, Long X, Lin K, Lu F, Xu JJ, Wu YB. Cancer cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC. Mol Cancer. 2021;20(1):144.

Kroy DC, Ciuffreda D, Cooperrider JH, Tomlinson M, Hauck GD, Aneja J, Berger C, Wolski D, Carrington M, Wherry EJ, Chung RT, Tanabe KK, Elias N, Freeman GJ, de Kruyff RH, Misdraji J, Kim AY, Lauer GM. Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors. Gastroenterology. 2014;146(2):550–61.

Wu Y, Ju Q, Jia K, Yu J, Shi H, Wu H, Jiang M. Correlation between sex and efficacy of immune checkpoint inhibitors (PD-1 and CTLA-4 inhibitors). Int J Cancer. 2018;143(1):45–51.

Alfei F, Kanev K, Hofmann M, Wu M, Ghoneim HE, Roelli P, Utzschneider DT, von Hoesslin M, Cullen JG, Fan Y, Eisenberg V, Wohlleber D, Steiger K, Merkler D, Delorenzi M, Knolle PA, Cohen CJ, Thimme R, Youngblood B, Zehn D. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral Infection. Nature. 2019;571(7764):265–9.

Sekine T, Perez-Potti A, Nguyen S, Gorin JB, Wu VH, Gostick E, Llewellyn-Lacey S, Hammer Q, Falck-Jones S, Vangeti S, Yu M, Smed-Sorensen A, Gaballa A, Uhlin M, Sandberg JK, Brander C, Nowak P, Goepfert PA, Price DA, Betts MR, Buggert M. TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells. Sci Immunol. 2020;5:49.

Wu P, Zhang H, Sun M, Mao S, He Q, Shi Y, Deng Y, Dong Z, Xu Q, Zhao C, Zhang W, Sun B. Manipulating offense and Defense Signaling to Fight Cold tumors with Carrier-Free Nanoassembly of Fluorinated Prodrug and siRNA. Adv Mater. 2022;34(38):2203019.

Abdel-Hakeem MS, Manne S, Beltra JC, Stelekati E, Chen Z, Nzingha K, Ali MA, Johnson JL, Giles JR, Mathew D, Greenplate AR, Vahedi G, Wherry EJ. Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation. Nat Immunol. 2021;22(8):1008–19.

Wang W, Saeed M, Zhou Y, Yang L, Wang D, Yu H. Non-viral gene delivery for cancer immunotherapy. J Gene Med 2019, 21 (7), e3092.

Huang X, Wu G, Liu C, Hua X, Tang Z, Xiao Y, Chen W, Zhou J, Kong N, Huang P, Shi J, Tao W. Intercalation-driven formation of siRNA nanogels for Cancer Therapy. Nano Lett. 2021;21(22):9706–14.

Wu P, Yin S, Liu T, Ding D, Wang K. Building-block crosslinking micelles for enhancing cellular transfection of biocompatible polycations. Sci China Mater 2020.

Li Z, Wang Y, Shen Y, Qian C, Oupicky D, Sun M. Targeting pulmonary Tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy. Sci Adv. 2020;6(20):eaaz9240.

Shen W, Wang Q, Shen Y, Gao X, Li L, Yan Y, Wang H, Cheng Y. Green Tea Catechin dramatically promotes RNAi mediated by low-molecular-weight polymers. ACS Cent Sci. 2018;4(10):1326–33.

Wu P, Zhang H, Yin Y, Sun M, Mao S, Chen H, Deng Y, Chen S, Li S, Sun B. Engineered EGCG-Containing Biomimetic nanoassemblies as effective delivery platform for enhanced Cancer Therapy. Adv Sci. 2022;9(15):2105894.

Rawangkan A, Wongsirisin P, Namiki K, Iida K, Kobayashi Y, Shimizu Y, Fujiki H, Suganuma M. Green Tea Catechin is an alternative Immune checkpoint inhibitor that inhibits PD-L1 expression and lung Tumor growth. Molecules. 2018;23(8):2071.

Gao Z, Jia S, Ou H, Hong Y, Shan K, Kong X, Wang Z, Feng G, Ding D. An Activatable Near-Infrared Afterglow Theranostic Prodrug with Self-sustainable magnification effect of immunogenic cell death. Angew Chem Int Ed Engl 2022, 61 (40), e202209793.

Li J, Gao H, Liu R, Chen C, Zeng S, Liu Q, Ding D. Endoplasmic reticulum targeted AIE bioprobe as a highly efficient inducer of immunogenic cell death. Sci China Chem. 2020;63(10):1428–34.

Wu P, Luo X, Wu H, Zhang Q, Dai Y, Sun M. Efficient and targeted chemo-gene delivery with self-assembled fluoro-nanoparticles for liver fibrosis therapy and recurrence. Biomaterials. 2020;261:120311.

Xiao YP, Zhang J, Liu YH, Huang Z, Wang B, Zhang YM, Yu XQ. Cross-linked polymers with fluorinated bridges for efficient gene delivery. J Mater Chem B. 2017;5(43):8542–53.

Yang P, Peng Y, Feng Y, Xu Z, Feng P, Cao J, Chen Y, Chen X, Cao X, Yang Y, Jie J. Immune Cell-Derived Extracellular vesicles - New Strategies in Cancer Immunotherapy. Front Immunol. 2021;12:771551.

Lv J, Cheng Y. Fluoropolymers in biomedical applications: state-of-the-art and future perspectives. Chem Soc Rev. 2021;50(9):5435–67.

Wang M, Liu H, Li L, Cheng Y. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios. Nat Commun. 2014;5:3053.

Xu J, Lv J, Zhuang Q, Yang Z, Cao Z, Xu L, Pei P, Wang C, Wu H, Dong Z, Chao Y, Wang C, Yang K, Peng R, Cheng Y, Liu Z. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy. Nat Nanotechnol. 2020;15(12):1043–52.

Ren F, Li Z, Li K, Zheng X, Shi J, Zhang C, Guo H, Tong B, Xi L, Cai Z, Dong Y. Donor strategy for promoting nonradiative decay to achieve an efficient photothermal therapy for treating cancer. Sci China Chem. 2021;64(9):1530–9.

Shao H, Cheng S, Yao M, Ji X, Zhong H, Wang D, Fan X, Li Q, Zhou J, Zhang Y, Peng F. A pH-response chemotherapy synergistic photothermal therapy for Tumor suppression and bone regeneration by mussel-inspired mg implant. Regen Biomater. 2021;8(6):rbab053.

Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara K, Sakaguchi S, Nishikawa H. PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc Natl Acad Sci U S A. 2019;116(20):9999–10008.

Yu X, Chen L, Liu J, Dai B, Xu G, Shen G, Luo Q, Zhang Z. Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver Metastasis. Nat Commun 2019, 10 (1).

Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, Rizvi SM, Qin A, Waninger JJ, Lang X, Chopra Z, El Naqa I, Zhou J, Bian Y, Jiang L, Tezel A, Skvarce J, Achar RK, Sitto M, Rosen BS, Su F, Narayanan SP, Cao X, Wei S, Szeliga W, Vatan L, Mayo C, Morgan MA, Schonewolf CA, Cuneo K, Kryczek I, Ma VT, Lao CD, Lawrence TS, Ramnath N, Wen F, Chinnaiyan AM, Cieslik M, Alva A, Zou W. Liver Metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 2021;27(1):152–64.

Song J, Jia X, Ariga K. Methods with Nanoarchitectonics for Small molecules and nanostructures to regulate living cells. Small Methods. 2020;4(10):2000500.

Li Q, Liu J, Fan H, Shi L, Deng Y, Zhao L, Xiang M, Xu Y, Jiang X, Wang G, Wang L, Wang Z. IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary Tumor growth and eradicates metastatic lesions by targeting distinct compartments within Tumor microenvironment. Biomaterials. 2021;269:120388.

Ni X, Zhang X, Duan X, Zheng HL, Xue XS, Ding D. Near-Infrared Afterglow luminescent aggregation-Induced Emission dots with Ultrahigh Tumor-to-liver Signal ratio for promoted image-guided Cancer Surgery. Nano Lett. 2019;19(1):318–30.

Zhao Z, Chen C, Wu W, Wang F, Du L, Zhang X, Xiong Y, He X, Cai Y, Kwok RTK, Lam JWY, Gao X, Sun P, Phillips DL, Ding D, Tang BZ. Highly efficient photothermal nanoagent achieved by harvesting energy via excited-state intramolecular motion within nanoparticles. Nat Commun. 2019;10(1):768.

Wu Q, Wang Q, Tang X, Xu R, Zhang L, Chen X, Xue Q, Wang Z, Shi R, Wang F, Ju F, Zhang B, Zhou YL. Correlation between patients’ age and cancer immunotherapy efficacy. Oncoimmunology 2019, 8 (4), e1568810.